Centralized public procurement in healthcare 2021
In 2021 State Enterprise “Medical Procurement of Ukraine” implements centralized procurement of medicines and medical devices within the public funds, allocated by the Ministry of Healthcare of Ukraine (MOH) following the Order of the MOH of Ukraine № 32 dated 12.01.2021.
The enumeration of the items for the procurement in 2021 was formed by the MOH and approved by the Cabinet of Ministers with the Order of the Cabinet of Ministers of Ukraine dated February 17, 2021, #132.
Our announced procedures can be followed on our dashboards (Ukr language).
In 2021 SE "Medical Procurement of Ukraine" performs procurements of medicines and medical devices for 19 areas, specifically:
- Chemotherapy medicines, radiopharmaceuticals and medicines that support treatment of cancer patients;
- Medicines and medical devices for the treatment of children with cancer and oncohematological diseases;
- Medicines to for adults with type A or B haemophilia or Willebrand's disease;
- Medicines for children with type A or B haemophilia or Willebrand's disease;
- Medicines and medical devices for healthcare facilities to provide treatment for patients with cardiovascular and cerebrovascular diseases;
- Medical devices for citizens suffering from idiopathic dystonia, torticollis, idiopathic oromandibular dystonia;
- Medicines for the treatment of patients with multiple sclerosis;
- Medicines for the treatment of citizens suffering from a resistant form of juvenile rheumatoid arthritis;
- Reagents for the mass screening of newborns for phenylketonuria, congenital hypothyroidism, cystic fibrosis and congenital adrenal hyperplasia;
- Medicines for citizens with congenital immunodeficiency disorders;
- Medicines and small laboratory equipment to ensure the treatment of infertility in women through assisted reproductive technologies;
- Medicines for citizens suffering from pulmonary hypertension;
- Medicines for children with cerebral palsy;
- Medicines for citizens with cystic fibrosis;
- Medicines for patients with infectious diseases accompanied by a high mortality rate;
- Medications for substitution maintenance therapy;
- Medicines for citizens suffering from orphan metabolic diseases;
- Medicines for antiretroviral therapy for adults, adolescents and children;
- Medicines for treatment of tuberculosis.
On the March 5, 2021 the MOH approved the allocation of the budget funds for the centralized public procurement for the 2021.
Centralized procurement in other areas are carried out by international specialized organizations following the Resolution of the Cabinet of Ministers of Ukraine. Information on these procedures can be found at the Ministry of Health of Ukraine.
Within the market consultations we hold the forum: "Public procurement in healthcare in 2021: organization and conduct of the procedures".
Link to the video in the English language.
Link to the presentation English language.